Works matching IS 03057453 AND DT 2016 AND VI 71 AND IP 2

Results: 41
    1
    2
    3
    4
    5

    Impact of the MIC of piperacillin/tazobactam on the outcome for patients with bacteraemia due to Enterobacteriaceae: the Bacteraemia-MIC project.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2016, v. 71, n. 2, p. 521, doi. 10.1093/jac/dkv362
    By:
    • Delgado-Valverde, Mercedes;
    • Torres, Eva;
    • Valiente-Mendez, Adoración;
    • Almirante, Benito;
    • Gómez-Zorrilla, Silvia;
    • Borrell, Núria;
    • Corzo, Juan E.;
    • Gurgui, Mercedes;
    • Almela, Manuel;
    • García-Álvarez, Lara;
    • Fontecoba-Sánchez, María Cruz;
    • Martínez-Martínez, Luis;
    • Cantón, Rafael;
    • Praena, Julia;
    • Causse, Manuel;
    • Gutiérrez-Gutiérrez, Belén;
    • Roberts, Jason A.;
    • Farkas, Andras;
    • Pascual, Álvaro;
    • Rodríguez-Baño, Jesús
    Publication type:
    Article
    6
    7
    8
    9
    10
    11
    12
    13
    14
    15
    16
    17
    18
    19
    20
    21
    22
    23
    24
    25
    26
    27

    Specific gyrA gene mutations predict poor treatment outcome in MDR-TB.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2016, v. 71, n. 2, p. 314, doi. 10.1093/jac/dkv360
    By:
    • Rigouts, L.;
    • Coeck, N.;
    • Gumusboga, M.;
    • de Rijk, W. B.;
    • Aung, K. J. M.;
    • Hossain, M. A.;
    • Fissette, K.;
    • Rieder, H. L.;
    • Meehan, C. J.;
    • de Jong, B. C.;
    • Van Deun, A.
    Publication type:
    Article
    28

    Drug transporter gene expression in human colorectal tissue and cell lines: modulation with antiretrovirals for microbicide optimization.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2016, v. 71, n. 2, p. 372, doi. 10.1093/jac/dkv335
    By:
    • Mukhopadhya, Indrani;
    • Murray, Graeme I.;
    • Berry, Susan;
    • Thomson, John;
    • Frank, Bruce;
    • Gwozdz, Garry;
    • Ekeruche-Makinde, Julia;
    • Shattock, Robin;
    • Kelly, Charles;
    • Iannelli, Francesco;
    • Pozzi, Gianni;
    • El-Omar, Emad M.;
    • Hold, Georgina L.;
    • Hijazi, Karolin
    Publication type:
    Article
    29
    30
    31
    32
    33

    A single-day point-prevalence study of faecal carriers in long-term care hospitals in Madrid (Spain) depicts a complex clonal and polyclonal dissemination of carbapenemase-producing Enterobacteriaceae.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2016, v. 71, n. 2, p. 348, doi. 10.1093/jac/dkv355
    By:
    • Ruiz-Garbajosa, Patricia;
    • Hernández-García, Marta;
    • Beatobe, Lorena;
    • Tato, Marta;
    • Méndez, María Isabel;
    • Grandal, Manuel;
    • Aranzábal, Lidia;
    • Alonso, Santiago;
    • Lópaz, María Ángeles;
    • Astray, Jenaro;
    • Cantón, Rafael
    Publication type:
    Article
    34
    35

    Susceptibility testing breakpoints for Mycobacterium tuberculosis categorize isolates with resistance mutations in gyrA as susceptible to fluoroquinolones: implications for MDR-TB treatment and the definition of XDR-TB.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2016, v. 71, n. 2, p. 333, doi. 10.1093/jac/dkv353
    By:
    • Niward, Katarina;
    • Ängeby, Kristian;
    • Chryssanthou, Erja;
    • Paues, Jakob;
    • Bruchfeld, Judith;
    • Jureen, Pontus;
    • Giske, Christian G.;
    • Kahlmeter, Gunnar;
    • Schön, Thomas
    Publication type:
    Article
    36
    37

    Carbapenems versus alternative antibiotics for the treatment of bloodstream infections caused by Enterobacter, Citrobacter or Serratia species: a systematic review with meta-analysis.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2016, v. 71, n. 2, p. 296, doi. 10.1093/jac/dkv346
    By:
    • Harris, Patrick N. A.;
    • Wei, Jane Y.;
    • Shen, Andrew W.;
    • Abdile, Ahmed A.;
    • Paynter, Stuart;
    • Huxley, Rachel R.;
    • Pandeya, Nirmala;
    • Yohei Doi;
    • Kyungmin Huh;
    • O'Neal, Catherine S.;
    • Talbot, Thomas R.;
    • Paterson, David L.
    Publication type:
    Article
    38

    The Innovative Medicines Initiative's New Drugs for Bad Bugs programme: European public-private partnerships for the development of new strategies to tackle antibiotic resistance.

    Published in:
    Journal of Antimicrobial Chemotherapy (JAC), 2016, v. 71, n. 2, p. 290, doi. 10.1093/jac/dkv339
    By:
    • Kostyanev, T.;
    • Bonten, M. J. M.;
    • O'Brien, S.;
    • Steel, H.;
    • Ross, S.;
    • François, B.;
    • Tacconelli, E.;
    • Winterhalter, M.;
    • Stavenger, R. A.;
    • Karlén, A.;
    • Harbarth, S.;
    • Hackett, J.;
    • Jafri, H. S.;
    • Vuong, C.;
    • MacGowan, A.;
    • Witschi, A.;
    • Angyalosi, G.;
    • Elborn, J. S.;
    • deWinter, R.;
    • Goossens, H.
    Publication type:
    Article
    39
    40
    41